Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-β1

Leukemia and Lymphoma

Volumn 46, Issue 4, 2005, Pages 599-602

  Okabe, Seiichi ^a   Miyazawa, Keisuke ^a   Iguchi, Tomotaka ^a   Sumi, Masahiko ^a   Takaku, Tomoiku ^a   Ito, Yoshikazu ^a   Kimura, Yukihiko ^a   Serizawa, Hiromi ^a   Mukai, Kiyoshi ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow; Myelofibrosis; Peripheral T cell lymphoma; TGF 1

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PIRARUBICIN; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1; VINCRISTINE SULFATE;

AGED; ARTICLE; BONE MARROW DISEASE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MALE; MYELOFIBROSIS; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN DEFECT;

AGED; BONE MARROW; FATAL OUTCOME; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MYELOFIBROSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 20244380948     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400029809     Document Type: Article

References (10)

1. Weinstein IM. Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev 1991;5:98-104.
2. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-1265.
3. Abe Y, Ohshima K, Shiratsuchi M, Honda K, Nishimura J, Nawata H, Muta K. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta. Eur J Haematol 2001;66:210-212.
4. Uehara E, Tasaka T, Matsuhashi Y, Fujita M, Tamura T, Shimoura Y, Mano S, Kuwajima M, Nagai M. Peripheral T-cell lymphoma presenting with rapidly progressing myelofibrosis. Leuk Lymphoma 2003;44:361-363.
5. Rao SA, Gottesman Sr, Nguyen MC, Braverman AS. T cell lymphoma associated with myelofibrosis. Leuk Lymph 2003;44:715-718.
6. Takai K, Sanada M. Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis. Rinsho Ketsueki 1989;30:2199-2204 [in Japanese].
7. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998;92:76-82.
8. Kimura A, Katoh O, Hyodo H, Kuramoto A. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol 1989;72:486-491.
9. Martyre MC. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 1995;20:39-44.
10. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358.